Síguenos en Twitter     Síguenos en Facebook     Síguenos en YouTube     Siguenos en Linkedin     Correo Salutsantjoan     Gmail     Dropbox     Instagram     Google Drive     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon     StumbleUpon


My photo
FACP. Colegio de médicos de Tarragona Nº 4305520 / fgcapriles@gmail.com




Monday, May 27, 2019

Cryptococcal Meningitis

emDocs - May 27, 2019 - Authors: Kathryn Fisher and Tim Montrief
Edited by Alex Koyfman and Brit Long
..."Take Home Points:
  • Cryptococcal meningitis (CM) is the most common cause of fungal meningitis and the most common cause of extrapulmonary cryptococcosis worldwide with over 220,000 cases per year, and a mortality of ~30% worldwide.
  • CM occurs primarily in immunocompromised patients. Patients with HIV, cancer, iatrogenic immunosuppression, transplants, drug or alcohol abuse, chronic kidney disease, diabetes and other immunodeficiencies are at high risk.
  • The clinical course of CM is variable, although it typically presents as a subacute meningoencephalitis characterized by an initially indolent course of neurological symptoms including headache, altered mental status, lethargy, fever, meningismus, nausea and vomiting for days to weeks that progressively worsens.
  • CM may be the initial AIDS-defining illness in up to 84% of patients.
  • Emergency providers must have a high index of suspicion for CM in the immunocompromised patient. This is especially true for patients with repeated visits for increasing and atypical neurological symptoms including headache.
  • Initial CSF studies (including India ink stain) may be normal in up to 17% of patients, especially in HIV-positive populations. CSF culture is the current gold-standard for ruling in or out CM, but commonly takes up to 10 days to result.
  • Patients should be treated empirically for bacterial, fungal, and viral meningitis.
  • Initial antifungal regimen for CM includes amphotericin B + flucytosine for 2 weeks"